Spring is in full bloom—and so is this month’s edition of your go-to resource for long-term care pharmacy success! As April winds down, we’re bringing you a fresh collection of insights, expert perspectives, and practical tools to help your pharmacy thrive. This issue is bursting with new ideas and innovative strategies designed to spark growth and accelerate innovation in your LTC pharmacy.
Ensure Your Pharmacy Meets Regulatory Standards
Staying compliant isn’t a one-time effort. It requires continuous monitoring, thorough documentation, ongoing staff training, and the right technology to streamline processes. A proactive approach helps LTC pharmacies avoid costly mistakes while maintaining the highest standard of care.
A Conversation with the VP of People at SoftWriters
In this episode of FrameworkFocus™, host Todd Eury sits down with Dori Armstead, VP of People at SoftWriters, to explore The Future of Work and what it means for the pharmacy technology industry. Dori shares insights on building a talent-centric organization, SoftWriters’ journey in improving hiring and retention, and how HR strategies are evolving to meet today’s workforce demands.
Building Strong Relationships with Facility Partners
Strong partnerships don’t happen automatically; they require open communication, reliable service, and a deep understanding of facility workflows. Here are six different ways to strengthen these relationships and improve collaboration.
The FrameworkLTC User Conference is now the FrameworkLTC Innovation Conference — a fresh name that reflects our continued focus on progress, insights, and transformation in Long-Term Care Pharmacy. Registration opens very soon (just days away!), and this event is for everyone on your team, from owners and operators to pharmacists and technicians. Join us in sunny San Diego this September for an unforgettable few days of learning, networking, and innovation.
Click below to be the first to know when registration opens!
On February 25, 2025, the FDA announced the removal of Risk Evaluation and Mitigation Strategy (REMS) requirements for clozapine, a medication used to treat treatment-resistant schizophrenia. This decision is widely supported by providers, patients, and caregivers, as it eliminates administrative burdens that have often led to dangerous treatment interruptions, relapses, and hospitalizations.
For LTC pharmacies, this change means:
No more REMS registration or special dispensing authorization for clozapine prescriptions.
Immediate updates to dispensing policies to align with the new FDA guidance.
A call to remove former REMS-related restrictions, such as quantity limits and lab result requirements.
While the FDA has lifted REMS requirements, some payer and corporate policies may still enforce restrictions. LTC pharmacies are now better equipped to ensure seamless access to clozapine for patients who rely on it. This is a critical opportunity to improve patient care and reduce preventable treatment disruptions.
.png?upscale=true&width=1116&upscale=true&name=RegulatoryDownload%20(1).png)
